Medicare Group Q.P.S.C. (QSE:MCGS)
Qatar · Delayed Price · Currency is QAR | Market Cap | 1.66B +23.9% |
| Revenue (ttm) | 502.60M -4.0% |
| Net Income | 76.01M +26.6% |
| EPS | 0.27 +26.6% |
| Shares Out | 281.44M |
| PE Ratio | 21.81 |
| Forward PE | 18.85 |
| Dividend | 0.22 (3.78%) |
| Ex-Dividend Date | Apr 1, 2026 |
| Volume | 937,160 |
| Open | 5.83 |
| Previous Close | 5.82 |
| Day's Range | 5.78 - 5.90 |
| 52-Week Range | 4.81 - 7.21 |
| Beta | 0.27 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 20, 2026 |
About Medicare Group Q.P.S.C.
Medicare Group Q.P.S.C. operates hospital and promotes medical services in Qatar. The company provides medical services through hospitals and engages in operating clinics. It also offers medical and therapeutic care services. The company was formerly known as Al Ahli Specialized Hospital Company Q.S.C. The company was founded in 1995 and is based in Doha, Qatar. [Read more]
Financial Performance
In 2025, Medicare Group Q.P.S.C.'s revenue was 502.60 million, a decrease of -3.99% compared to the previous year's 523.49 million. Earnings were 76.01 million, an increase of 26.57%.
Financial StatementsNews
All Eyes Are on Social Security's Financial Woes. But Medicare Is in Trouble, Too.
This could be a huge blow to many seniors' budgets.
Medicare Launches GLP-1 Bridge Program for Weight Loss Drugs
Medicare Launches GLP-1 Bridge Program for Weight Loss Drugs
Medicare Expands Coverage for GLP-1 Weight Loss Drugs, Retailers Step In
Medicare Expands Coverage for GLP-1 Weight Loss Drugs, Retailers Step In
Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs
Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an important role for patients.
Medicare Expands Access to GLP-1 Drugs, Boosting Eli Lilly (LLY) and Novo Nordisk (NVO)
Medicare Expands Access to GLP-1 Drugs, Boosting Eli Lilly (LLY) and Novo Nordisk (NVO)
Medicare Launches GLP-1 Bridge Program for Weight Loss Medications
Medicare Launches GLP-1 Bridge Program for Weight Loss Medications
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.
Who qualifies for Medicare's new $50 weight-loss drug program and what are the concerns?
Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on Wednesday in its Medicare program for people aged 65 and older or with disabilit...
Medicare Expands Coverage for GLP-1 Weight Loss Drugs Boosting Novo Nordisk (NVO)
Medicare Expands Coverage for GLP-1 Weight Loss Drugs Boosting Novo Nordisk (NVO)
Medicare Launches GLP-1 Bridge Program for Obesity Treatment
Medicare Launches GLP-1 Bridge Program for Obesity Treatment
Medicare will start covering obesity drugs for the first time. Here's what patients should know
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the government or Eli Lilly and Novo.
Medicare's New GLP-1 Bridge Program Boosts Access to Eli Lilly's (LLY) Weight Loss Drugs
Medicare's New GLP-1 Bridge Program Boosts Access to Eli Lilly's (LLY) Weight Loss Drugs
Medicare to launch GLP-1s for $50: Here's what to know
CNBC’s Angelica Peebles reports on the latest news.
Millions of older Americans will soon have Medicare access to GLP-1s for weight loss. Here’s what they need to know.
Starting July 1, Medicare beneficiaries will have access to weight-loss drugs for the first time. There are some unique factors they should consider.
Social Security’s woes are well known, but Medicare is also facing a fiscal crisis — in just 7 years
Medicare Part A, which pays for inpatient hospital stays, would see an 11% payment cut.
Eli Lilly CEO: Obesity-care should be healthcare
At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Lilly CEO Dave Ricks to discuss what his expectations are for insurance coverage of GLP-1s and Me...
Private medical imaging provider bills Medicare for non-eligible services
Private medical imaging provider bills Medicare for non-eligible services
How Clear and CMS are bringing better technology to Medicare
Caryn Seidman Becker, CLEAR Chairman and CEO, and Chris Klomp, CMS Deputy Administrator and Director of Medicare, spoke with CNBC's Becky Quick at the CNBC CEO Council Summit in Washington, D.C., abou...
Pharma’s legal assault on Medicare negotiations hits a SCOTUS wall
Supreme Court decision not to hear pharma cases gives “strong signal” that Medicare price talks will continue.
Supreme Court rejects appeals over Medicare price negotiations
The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.
JD Vance threatens health funding to states that don’t comply with White House anti-fraud effort
Medicare has already paused hospice and home healthcare agency signups as potential fraud is investigated US politics live – latest updates JD Vance has threatened to “turn off” federal funding for go...
Medicare’s new payment model is built for AI, and most of the tech world has no idea
There is no governmental mechanism to pay for an AI agent that monitors a patient between visits, calls to check in, coordinates a housing referral, or makes sure someone picks up their medication. AC...
US woman pleads guilty to $6.9 million Medicare fraud through false billing over 3 years
US News: A Tennessee optometrist has pleaded guilty to a multimillion-dollar healthcare fraud scheme that federal prosecutors say cheated Medicare and other go.
Medicare Extends Coverage for Weight Loss Drugs, Impacting Novo (NVO) and Lilly (LLY)
Medicare Extends Coverage for Weight Loss Drugs, Impacting Novo (NVO) and Lilly (LLY)